Ponvory™ (ponesimod) – New drug approval
March 19, 2021 - Janssen announced the FDA approval of Ponvory (ponesimod), for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Top